Prognostic Role of Subsequent Atrial Tachycardias Occurring During Ablation of Persistent Atrial Fibrillation: A Prospective Randomized Trial

• Published in: Circulation. Arrhythmia and electrophysiology Vol. 6; no. 6; pp. 1059 - 1065
• Main Authors: Rostock, Thomas, Salukhe, Tushar V, Hoffmann, Boris A, Steven, Daniel, Berner, Imke, Müllerleile, Kai, Theis, Cathrin, Bock, Karsten, Servatius, Helge, Sultan, Arian, Willems, Stephan
• Format: Journal Article
• Language: English
• Published: United States American Heart Association, Inc 01.12.2013
• Subjects: Aged; Atrial Fibrillation - complications; Atrial Fibrillation - physiopathology; Atrial Fibrillation - surgery; Catheter Ablation; Electric Countershock; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Prognosis; Prospective Studies; Tachycardia, Ectopic Atrial - complications; atrial fibrillation; catheter ablation; tachycardia, ectopic atrial; arrhythmias cardiac
• ISSN: 1941-3149; 1941-3084
• DOI: 10.1161/CIRCEP.113.001019

BACKGROUND—The role of subsequent atrial tachycardias (AT) in the context of persistent atrial fibrillation (AF) remains undetermined. This study evaluated the prognostic role of subsequent ATs for arrhythmia recurrences after catheter ablation of persistent AF. METHODS AND RESULTS—A total of 110 patients with persistent AF (63±9 years; 22 women; 61 long-lasting persistent AF) underwent pulmonary vein isolation followed by electrogram-guided ablation. After AF terminated to AT, patients were separated by the randomization protocol to receive either direct cardioversion (group A) or further ablation of subsequent ATs to sinus rhythm (group B). After a mean follow-up of 20.1±13.3 months after the first procedure, significantly more group B patients were in sinus rhythm as compared with patients in group A (30 [57%] versus 18 [34%]; P=0.02). Moreover, recurrences of AF were significantly less frequent of group B than in group A patients (10 [19%] versus 26 [49%]; P=0.001). After the last procedure (follow-up, 34.0±6.4 months), significantly more group B patients were free of AF as compared with patients of group A (49 [92%] versus 39 [74%]; P=0.01). The proportion of AT recurrences did not differ between the 2 groups after the first and final procedures. The strongest predictor for an arrhythmia-free survival after a single procedure was randomization to the procedural end point of termination to sinus rhythm by elimination of subsequent ATs (P=0.004). CONCLUSIONS—Catheter ablation of subsequent ATs increases freedom from AF but not AT, suggesting a contributing role of subsequent ATs in the mechanisms of persistent AF. CLINICAL TRIAL REGISTRATION—URLhttp://www.clinicaltrials.gov. Unique identifierNCT01896570.